|
|
Volumn 352, Issue 25, 2005, Pages 2578-2580
|
|
Tailoring arthritis therapy in the wake of the NSAID crisis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CORTICOSTEROID;
CYCLOOXYGENASE 2 INHIBITOR;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROFECOXIB;
VALDECOXIB;
LACTONE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
SULFONE;
ARTHRITIS;
BLEEDING;
CARDIOVASCULAR DISEASE;
CLINICAL FEATURE;
CONNECTIVE TISSUE DISEASE;
DOSE RESPONSE;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL DISEASE;
HUMAN;
INFLAMMATION;
LOW DRUG DOSE;
MEDICAL PRACTICE;
MOUTH ULCER;
PAIN;
PATIENT CARE;
PHYSICIAN;
PRIORITY JOURNAL;
RHEUMATOLOGY;
SHORT SURVEY;
SIDE EFFECT;
ULCER;
ARTICLE;
RISK ASSESSMENT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
LACTONES;
PYRAZOLES;
RISK ASSESSMENT;
SULFONAMIDES;
SULFONES;
|
|
EID: 20544432452
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp058105 Document Type: Short Survey |
|
Times cited : (16)
|
|
References (0)
|
